Properties
Description
SBE13 is an CDK kinase inhibitor that disrupts cell division processes. It targets PLK1 and PLK3.
Molecular Formula
C24H27ClN2O4
Targets
PLK1: 200 pM; PLK3: 875 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
SBE13 can be utilized to explore its inhibition of CHK1 and its potential to enhance the effects of radiation therapy in cancer treatment.